Imetelstat Combination Therapy
A Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia That is in Second or Greater Relapse or That is Refractory to Relapse Therapy; Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia in First or Greater Relapse or is Refractory to Relapse Therapy
Near Add Your Location
Sorting 19 by
- Accepting patients
MDS Center of Excellence
A Center of Excellence as recognized by the MDS Foundation, is a hospital that has demonstrated its commitment to MDS research. This is accomplished by conducting specialized genetic testing, offering ongoing clinical trials for MDS patients, and actively participating in peer-reviewed MDS research.
University of Minnesota - Masonic Cancer Center
Minneapolis, MN
- Accepting patients
MDS Center of Excellence
A Center of Excellence as recognized by the MDS Foundation, is a hospital that has demonstrated its commitment to MDS research. This is accomplished by conducting specialized genetic testing, offering ongoing clinical trials for MDS patients, and actively participating in peer-reviewed MDS research.
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
- Accepting patients
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
- Accepting patients
Children's National Medical Center
Washington, DC
- Accepting patients
UPMC Children's Hospital of Pittsburgh
Pittsburgh, PA
- Accepting patients
Children's of Alabama
Birmingham, AL
- Accepting patients
St. Jude Children's Research Center
Memphis, TN
- Accepting patients
Children's Hospital of Philadelphia
Philadelphia, PA
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.